ES2094160T3 - Peptidos terapeuticos, en particular analogos del peptido substancia p. - Google Patents
Peptidos terapeuticos, en particular analogos del peptido substancia p.Info
- Publication number
- ES2094160T3 ES2094160T3 ES90912128T ES90912128T ES2094160T3 ES 2094160 T3 ES2094160 T3 ES 2094160T3 ES 90912128 T ES90912128 T ES 90912128T ES 90912128 T ES90912128 T ES 90912128T ES 2094160 T3 ES2094160 T3 ES 2094160T3
- Authority
- ES
- Spain
- Prior art keywords
- amino acid
- peptide
- acid residue
- therapeutic peptides
- active site
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
UN PEPTIDO LINEAL ANALOGO AL QUE NATURALMENTE OCURRE, SUSTANCIA P BIOLOGICAMENTE ACTIVA TENIENDO UN SITIO ACTIVO Y UN SITIO DE FIJACION RESPONSABLE DE LA FIJACION DE DICHO PEPTIDO A UN RECEPTOR EN LA CELULA BLANCO. EL ANALOGO TIENE UN ENLACE NO PEPTIDICO, EN LUGAR DE UN ENLACE PEPTIDICO, ENTRE UN RESIDUO AMINOACIDO DEL SITIO ACTIVO MENCIONADO Y UN RESIDUO AMINOACIDO ADYACENTE, O UN RESIDUO SINTETICO, UN BETA AMINOACIDO , O UN GAMMA AMINOACIDO EN LUGAR DE LOS DOS RESIDUOS AMINOACIDOS DEL SITIO ACTIVO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39472789A | 1989-08-16 | 1989-08-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2094160T3 true ES2094160T3 (es) | 1997-01-16 |
Family
ID=23560172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90912128T Expired - Lifetime ES2094160T3 (es) | 1989-08-16 | 1990-08-16 | Peptidos terapeuticos, en particular analogos del peptido substancia p. |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0438566B1 (es) |
JP (1) | JPH04502922A (es) |
AT (1) | ATE143372T1 (es) |
CA (1) | CA2039175A1 (es) |
CZ (2) | CZ285562B6 (es) |
DD (1) | DD298411A5 (es) |
DE (1) | DE69028692T2 (es) |
DK (1) | DK0438566T3 (es) |
ES (1) | ES2094160T3 (es) |
GR (1) | GR900100613A (es) |
HU (1) | HUT65465A (es) |
IE (1) | IE77033B1 (es) |
PT (1) | PT95016B (es) |
SK (1) | SK402890A3 (es) |
WO (1) | WO1991002745A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5410019A (en) * | 1987-09-24 | 1995-04-25 | The Administrators Of The Tulane-Educational Fund | Therapeutic peptides |
FR2680174A1 (fr) * | 1991-08-05 | 1993-02-12 | Michelot Robert | Nouveaux composes peptidiques, inhibiteurs de l'adsorption du virus hiv sur ses cellules cibles. |
EP0533280B2 (en) | 1991-09-20 | 2004-12-01 | Glaxo Group Limited | Novel medical use for tachykinin antagonists |
US6156725A (en) * | 1996-08-16 | 2000-12-05 | National Institute Of Immunology | Drug for the treatment of cancer |
US6492330B1 (en) | 1996-08-16 | 2002-12-10 | National Institute Of Immunology | Antiangiogenic drugs |
EP0835662B1 (en) * | 1996-10-08 | 2001-11-14 | National Institute of Immunology | A drug for the treatment of cancer |
CA2225185A1 (en) | 1997-08-11 | 1999-02-11 | Peter K. Law | Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities |
US6316414B1 (en) | 2000-07-31 | 2001-11-13 | Dabur Research Foundation | Somatostatin analogs for the treatment of cancer |
WO2008090117A1 (en) | 2007-01-24 | 2008-07-31 | Glaxo Group Limited | Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1 |
US20120225817A1 (en) * | 2009-11-11 | 2012-09-06 | Santen Pharmaceutical Co., Ltd. | Therapeutic agent for gastrointestinal disease |
US9446029B2 (en) | 2010-07-27 | 2016-09-20 | Colorado State University Research Foundation | Use of NK-1 receptor antagonists in management of visceral pain |
AR128311A1 (es) * | 2022-01-21 | 2024-04-17 | Inst Pasteur De Montevideo | Inmunización activa para reducir el dolor osteoarticular, neuropático y en cáncer |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3862114A (en) * | 1971-11-22 | 1975-01-21 | Ici Australia Ltd | Analogs of substance p |
IT1212508B (it) * | 1981-12-22 | 1989-11-22 | Anic Spa | Analoghi retro - invertiti dei penta - ed esapeptidi c - terminali della sostanza p. utili come vasodilatatori |
US4481139A (en) * | 1983-04-13 | 1984-11-06 | Board Of Regents, The University Of Texas System | Peptide antagonists of substance P |
US4803261A (en) * | 1986-06-27 | 1989-02-07 | The Administrators Of The Tulane Educational Fund | Method for synthesizing a peptide containing a non-peptide |
NZ229552A (en) * | 1988-06-20 | 1992-06-25 | Merrell Dow Pharma | Neurokinin a antagonists |
-
1990
- 1990-08-15 IE IE295890A patent/IE77033B1/en not_active IP Right Cessation
- 1990-08-16 ES ES90912128T patent/ES2094160T3/es not_active Expired - Lifetime
- 1990-08-16 DD DD90343501A patent/DD298411A5/de not_active IP Right Cessation
- 1990-08-16 DE DE69028692T patent/DE69028692T2/de not_active Expired - Fee Related
- 1990-08-16 DK DK90912128.7T patent/DK0438566T3/da active
- 1990-08-16 CZ CZ99774A patent/CZ285562B6/cs not_active IP Right Cessation
- 1990-08-16 WO PCT/US1990/004633 patent/WO1991002745A1/en active IP Right Grant
- 1990-08-16 PT PT95016A patent/PT95016B/pt not_active IP Right Cessation
- 1990-08-16 SK SK4028-90A patent/SK402890A3/sk unknown
- 1990-08-16 HU HU906872A patent/HUT65465A/hu unknown
- 1990-08-16 GR GR900100613A patent/GR900100613A/el unknown
- 1990-08-16 JP JP2511667A patent/JPH04502922A/ja active Pending
- 1990-08-16 CZ CS904028A patent/CZ285319B6/cs not_active IP Right Cessation
- 1990-08-16 AT AT90912128T patent/ATE143372T1/de not_active IP Right Cessation
- 1990-08-16 CA CA002039175A patent/CA2039175A1/en not_active Abandoned
- 1990-08-16 EP EP90912128A patent/EP0438566B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
GR900100613A (el) | 1991-12-30 |
DE69028692D1 (de) | 1996-10-31 |
EP0438566A1 (en) | 1991-07-31 |
IE77033B1 (en) | 1997-11-19 |
EP0438566B1 (en) | 1996-09-25 |
SK280796B6 (sk) | 2000-07-11 |
CZ285562B6 (cs) | 1999-09-15 |
HUT65465A (en) | 1994-06-28 |
PT95016B (pt) | 1997-05-28 |
PT95016A (pt) | 1991-04-18 |
ATE143372T1 (de) | 1996-10-15 |
SK402890A3 (en) | 2000-07-11 |
CZ402890A3 (cs) | 1999-04-14 |
WO1991002745A1 (en) | 1991-03-07 |
JPH04502922A (ja) | 1992-05-28 |
CZ285319B6 (cs) | 1999-07-14 |
IE902958A1 (en) | 1991-02-27 |
DE69028692T2 (de) | 1997-02-20 |
EP0438566A4 (en) | 1993-03-31 |
HU906872D0 (en) | 1991-07-29 |
DD298411A5 (de) | 1992-02-20 |
DK0438566T3 (da) | 1996-11-11 |
CA2039175A1 (en) | 1991-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE139540T1 (de) | Heilmittelpeptide | |
DE3852086D1 (de) | Therapeutische Peptide. | |
DK66391A (da) | Terapeutisk virksomme peptider | |
ES2094160T3 (es) | Peptidos terapeuticos, en particular analogos del peptido substancia p. | |
ES2124685T3 (es) | Variantes del inhibidor de la tripsina pancreatica bovina, su produccion y uso. | |
PT699686E (pt) | Fragmentos de peptido insulinotropico do tipo glucagona biologicamente activos | |
MX9203175A (es) | Composicion de implante que contiene un peptido, polipeptido o proteina biologicamente activa y procedimiento para su preparacion. | |
Kiso et al. | Neo‐kyotorphin (Thr—Ser—Lys—Tyr—Arg), a new analgesic peptide | |
ES2112921T3 (es) | Peptidos y anticuerpos para el tratamiento de la artritis reumatoide. | |
ATE46173T1 (de) | Pharmakologisch aktive peptide. | |
ATE129744T1 (de) | Rekombinantes c-terminal alpha amidatierungsenzym von menschlischem thyroidursprung. | |
PT95057A (pt) | Processo para a preparacao de peptidos terapeuticos | |
PT93320A (pt) | Processo para a preparacao de peptideos terapeuticos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 438566 Country of ref document: ES |